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The American Academy of Pediatrics recommends donor human milk (DHM) as the preferred 
feeding strategy for preterm infants when the milk of the mother is unavailable, based on 
conclusive evidence of lower rates of necrotizing enterocolitis with DHM feedings compared 
with preterm infant formula. The nutritional composition of DHM may differ from maternal milk 
for many reasons including differences in maternal characteristics, milk collection methods, and 
the impact of donor milk banking practices. The purpose of this systematic review is to examine 
the literature regarding research on the fat, protein, carbohydrate, vitamin, and mineral 
composition of DHM obtained through nonprofit milk banks or commercial entities. PubMed, 
CINAHL, and Scopus databases were searched for articles published between 1985 and 30 April, 
2019. In total, 164 abstracts were screened independently by 2 investigators, and 14 studies met 
all inclusion criteria. Studies were predominantly small (<50 samples) and measured 
macronutrients. Few studies assessed vitamins and minerals. Information bias was prevalent due 
to the use of a variety of analytical methods which influence accuracy and cross-study 
comparisons. Other sources of information bias included missing information regarding methods 
for protein and calorie assessment. Despite these limitations, existing research suggests the 
potential for 2-fold and greater differences in the fat, protein, and energy composition of DHM, 
with mean values for energy and fat often below clinical reference values expected for human 
milk. Further research is warranted regarding the nutritional composition of DHM, with a 
prioritization on measuring macronutrients and micronutrients using established reference 
methods. 
 






The American Academy of Pediatrics (AAP) recommends donor human milk (DHM) as the 
preferred feeding strategy for preterm infants when the milk of the mother is unavailable, based 
on conclusive evidence of lower rates of necrotizing enterocolitis with use of DHM feedings 
compared with preterm infant formula (1–4). In its most recent assessment of maternity hospital 
practices, the CDC found that over 65% of neonatal intensive care units in the USA use DHM, 
suggesting wide adoption of DHM recommendations (5). Unfortunately, DHM use is also 
associated with inferior in-hospital preterm infant growth compared with preterm formula and 
maternal milk, raising concerns about long-term outcomes (3, 6, 7). 
 
 
FIGURE 1. Overview of milk bank processes and potential sources of variation compared with 
milk from the mother that may influence nutritional reference values for donor human milk. 
Milk-print, a larger subject effect than temporal effect on many of the nutrients in human milk. 
 
Poorer growth with DHM feedings may be related to the inadequate nutrient composition of 
DHM compared with other feeding options. While there are multiple reviews on the composition 
 
  Abbreviations used: AAP, American Academy of Pediatrics; BCA, bicinchoninic acid; DHM, donor human milk; 
HMBANA, Human Milk Banking Association of North America; HMO, human milk oligosaccharides. 
of maternal milk (8, 9), a 2017 working group of the NIH concluded that “the limited scope of 
human milk research initiatives has led to a lack of robust estimates of the composition and 
volume of human milk consumed and, consequently, missed opportunities to improve maternal 
and infant health” (10). Even with improved knowledge regarding the nutrient composition of 
maternal milk, new findings may not be generalizable to DHM due to additional sources of 
variation in DHM (Figure 1) including: a wide variety of donors (e.g., by gestation stage, 
lactation stage, maternal diet); inconsistency in milk collection methods (including incomplete 
breast expression leading to fat loss); evidence of a human “milk-print,” with who the milk was 
collected from as a better predictor of nutrient composition than the stage of lactation (11); 
additional impact of milk banking processes (e.g., pooling, mixing, multiple container transfers) 
that may influence nutrient distribution and retention in DHM; as well as the documented loss of 
some bioactive factors and nutrients during pasteurization and storage (12). 
 
Information regarding the nutrient composition of DHM may enable the development of 
improved preterm infant feeding protocols including the formulation of DHM-specific fortifiers 
or modification of existing fortification strategies. It may also help inform quality improvement 
initiatives and future research within donor milk banking practices. Therefore, the purpose of this 
review was to examine the literature regarding research on the nutrient composition of DHM 
obtained through milk banks and commercial entities. The goal of the review was to characterize 





We conducted a systematic search of original peer-reviewed research published between 1 
January, 1985 (founding year of the Human Milk Banking Association of North America; 
HMBANA) and 30 April, 2019 to identify studies providing quantitative data on the nutritional 
composition of DHM obtained from milk banks or commercial entities worldwide. The Preferred 
Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) checklist was used to 
guide the review process. Electronic searches of PubMed, Scopus, and CINHAL databases were 
performed using the following search term: ((“donor milk” OR “donor human milk” OR “milk 
banks” OR “milk bank” OR (Donat* AND milk)) AND (composition OR nutrients) NOT 
review. Advanced filters included articles that were based on human subjects only and articles 
that were published in English. 
 
The abstracts for all studies identified in the initial search were independently assessed by 2 
researchers (EAB and MTP). Abstracts were excluded from further review if they did not 
mention DHM or if they did not assess the nutritional composition of DHM. Abstracts that 
passed the initial review were subject to a full article review by 2 independent reviewers (EAB 
and MTP). Studies were excluded for the following reasons: donor milk was created in a 
laboratory versus a milk bank or commercial setting; only nonnutritional factors were assessed 
(e.g., hormones, cytokines); studies did not reflect normal milk banking processes (e.g., use of 
additional donor exclusion criteria); inconsistencies between methods and results (e.g., inability 
to distinguish data that represented mother versus donor milk); and data not reported for DHM 
samples. Where information was lacking to assess exclusion criteria, we contacted the primary 
study author to request the relevant information. Hand searches of bibliographies were also 
conducted to identify additional potential studies for review. 
 
Studies that met the inclusion criteria were abstracted by 2 reviewers (EAB and MTP) for the 
following information: source of donor milk, milk processing method, number of samples, donor 
characteristics, number of donors per sample, nutrients assessed, analytical methods, descriptive 
statistics, and funding source. In instances where reviewers did not agree, differences were 
resolved by discussion with a third reviewer (LT). Potential sources of bias were identified by 2 
reviewers (EAB, MTP) and feedback was obtained from all coauthors. The following sources of 
bias were considered qualitatively: information bias (did analytical methods influence findings or 
was key information omitted); selection bias (did source of DHM samples influence findings); 
and funding bias (did funders have financial interest in the topic and were they involved in study 
design or data interpretation). 
 
 
FIGURE 2. Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 
flow diagram of the literature search process to identify studies addressing nutrient composition 





An overview of the search and review process is described in Figure 2. The initial search 
identified 162 studies after the removal of duplicates, with 2 additional studies identified through 
a hand search of bibliographies. After review of the abstracts, a total of 128 studies were 
excluded because they were not about donor milk or related to donor milk composition, leaving 
36 studies for full review. Twenty-two studies were excluded after a full article review leaving 
14 studies in this systematic review of DHM composition. Included studies were conducted 
between 1995 and 2019 and mostly reflected DHM that was produced within the HMBANA 
milk bank network (Table 1) (13–26). Only 1 study examined milk that was produced by a 
commercial entity (25) and only 4 contained >50 DHM samples. The nutrient concentrations, milk 
characteristics, and analytical methods reported in the included studies are summarized by 
nutrient in Table 2. 
 
TABLE 1. Summary of studies included in the review of composition of donor human milk 
obtained from milk banks or commercial entities 
Author Year 
No. of 
samples Milk sources Outcome variables Funding source 
Luukkainen (13)  1995 48 Finland MB  Fatty acids  Yrjo Jahnsson Foundation; The 
Foundation for Pediatric Research  
Goes (14)  2002 60 Brazil MB  Calcium, copper, fat, lactose, iron, 
phosphorus, protein, vitamin A, 
zinc  
CNFq, FAPERJ, FINEP, and FUJB  
Valentine (15)  2010 16 HMBANA (1 MB)  Amino acids, LCPUFAs, total 
protein  
Research Institute at Nationwide 
Children's Hospital  
de Halleux (16)  2013 376 Belgium MB  Carbohydrates, energy, fat, protein  None  
Radmacher (17)  2013 6 HMBANA (1 MB)  Carbohydrates, energy, total fat, 
total protein  
None  
Marx (18)  2014 31 HMBANA (1 MB)  Total HMOs  German Academic Exchange 
Service Research Fellowship  
Perrella (19)  2015 15 Australia MB  Energy, fat, lactose, protein  Medela research grant  
Hanson (20)  2016 1 HMBANA (1 MB)  Vitamins – retinol, α-tocopherol, β-
carotene  
University of Nebraska Medical 
Center  
Barbarska (21)  2017 179 Poland MB  Carbohydrates, crude protein, 
energy, fat, true protein  
None  
Perrin (22)  2016 33 HMBANA (2 MB)  Carbohydrates, minerals, total fat, 
total HMOs, total protein  
North Carolina State University; 
American Society of Nutrition 
predoctoral fellowship; research 
gifts from HMBANA milk banks  
Donovan (23)  2017 37 HMBANA (1 MB)  Carbohydrates, energy, total fat, 
total protein  
Gerber Foundation  
Moukarzel (24)  2017 30 HMBANA (1 MB)  Total fat, total protein, water-
soluble choline  
None  
Meredith-Dennis(25)  2018 9 HMBANA (1 MB), 
Medolac, Prolacta  
Carbohydrates, energy, total fat, 
total HMOs, total protein  
NIH; University of California, 
Davis  
John (26)  2019 1111 HMBANA (1 MB)  Total fat, total protein  National Science Foundation  
CNPq, Brazilian Council for Scientific and Technological Development; FAPERJ, Carols Chagas Foundation for 
Research Support of the State of Rio de Janeiro; FINEP, Funding Authority for Studies and Projects; FUJB, Jose 
Bonifacio University Foundation; HMBANA, Human Milk Banking Association of North America; HMO, human 
milk oligosaccharides; LCPUFA, long chain PUFAs; MB, milk bank. 
 
TABLE 2. Nutrient concentrations in donor human milk obtained from milk banks or commercial entities 
Nutrient (citation) N Mean ± SD Range Treatment Donor type Donors/pool Analytical method 
Carbohydrates          
 Lactose, g/dL (14)  60 7.3 ± 1.6 — Holder n/a 1 Picric acid method  
 Lactose, g/dL (17)  6 6.1 ± 0.4 5.5–6.7 Holder n/a n/a Mid-IR  
 Lactose, g/dL (19)  15 6.6 ± 0.8 5.7–8.6 Holder n/a n/a Enzymatic  
 Lactose, g/dL (22)  33 5.6 ± 0.7 — Raw n/a n/a LC-MS/MS  
 Total carbohydrates, g/dL (16)  138 6.9 ± 0.4 — Holder n/a 1 FT Mid-IR  
 Total carbohydrates, g/dL (16)  224 6.8 ± 0.2 — Holder n/a Multiple FT Mid-IR  
 Total carbohydrates, g/dL (16)  14 6.5 ± 0.1 — Holder Colostrum n/a FT Mid-IR  
 Total carbohydrates, g/dL (21)  179 7.4 ± 0.3 — Raw n/a 1 Mid-IR  
 Total carbohydrates, g/dL (23)  16 6.8 ± 0.2 — Holder Preterm n/a FT Mid-IR  
 Total carbohydrates, g/dL (23)  21 6.7 ± 0.2 — Holder Term n/a FT Mid-IR  
 Total carbohydrates, g/dL (25)  3 — 7.2–7.3 Holder 11% preterm 2 FT Mid-IR  
 Total carbohydrates, g/dL (25)  3 — 7.0–7.2 Vat Holder n/a 250 FT Mid-IR  
 Total carbohydrates, g/dL (25)  3 — 7.0–7.2 Retort n/a 200 FT Mid-IR  
 Total HMOs, g/L (18)  31 — 4–16* Holder n/a 3 HPLC  
 Total HMOs, g/L (22)  33 9.3 ± 2.0 — Raw n/a  LC-MS/MS  
 Total HMOs, g/L (25)  3 12.6 ± 0.8 12.0–13.5 Holder 11% preterm 2 UPLC-MRM/MS  
 Total HMOs, g/L (25)  3 8.2 ± 0.1 8.1–8.4 Vat Holder n/a 250 UPLC-MRM/MS  
 Total HMOs, g/L (25)  3 6.6 ± 0.8 5.7–7.2 Retort n/a 200 UPLC-MRM/MS  
Energy, kcal/dL (16)  138 64.1 ± 5.9 — Holder n/a 1 FT Mid-IR + Atwater  
Energy, kcal/dL (16)  224 63.6 ± 4.5 — Holder n/a Multiple FT Mid-IR + Atwater  
Energy, kcal/dL (16)  14 60.3 ± 3.5 — Holder Colostrum n/a FT Mid-IR + Atwater  
Energy, kcal/dL (17)  6 49.3 ± 4.7 44.3–56.1 Holder n/a n/a Mid-IR + Atwater  
Energy, kcal/dL (19)  15 63.9 ± 12.2 42.6–84.8 Holder n/a n/a Proximate + Atwater  
Energy, kcal/dL (21)  179 61.7 ± 6.5 46.0–86.0 Raw n/a 1 Mid-IR  
Energy, kcal/dL (23)  21 64.9 — Holder Term n/a FT Mid-IR  
Energy, kcal/dL (23)  16 69.3 — Holder Preterm n/a FT Mid-IR  
Energy, kcal/dL (25)  3 64.6 ± 8.5 58.1–74.0 Holder 11% preterm 2 FT Mid-IR + Atwater  
Energy, kcal/dL (25)  3 69.0 ± 1.4 67.6–70.3 Vat Holder n/a 250 FT Mid-IR + Atwater  
Energy, kcal/dL (25)  3 58.8 ± 5.7 52.4–62.9 Retort n/a 200 FT Mid-IR + Atwater  
Fat          
 LCPUFA          
  α-Linolenic acid, % wt (13)  48 0.9 0.6–1.6 Raw Transition 1–3 GC  
  α-Linolenic acid, nmol/mL (15)  16 8.3 ± 1.2 — Holder Term/preterm 3–4 GC  
  Arachidonic acid, % wt (13)  48 0.5 0.2–0.8 Raw Transition 1–3 GC  
  Arachidonic acid, nmol/mL (15)  16 2.7 ± 0.4 — Holder Term/preterm 3–4 GC  
  DHA, % wt (13)  48 0.5 0.2–0.8 Raw Transition 1–3 GC  
  DHA, nmol/mL (15)  16 0.7 ± 0.2 — Holder Term/preterm 3–4 GC  
  Linoleic acid, % wt (13)  48 9.1 6.3–13.4 Raw Transition 1–3 GC  
Nutrient (citation) N Mean ± SD Range Treatment Donor type Donors/pool Analytical method 
  Linoleic acid, nmol/mL (15)  16 118 ± 18 — Holder Term/preterm 3–4 GC  
 Monounsaturated, % wt (13)  48 42.2 37.1–48.4 Raw Transition 1–3 GC  
 Saturated, % wt (13)  48 46.4 37.7–50.1 Raw Transition 1–3 GC  
 Total fat, g/dL (14)  60 1.8 ± 1.1 — Holder n/a 1 Creamatocrit  
 Total fat, g/dL (16)  138 3.5 ± 0.6 — Holder n/a 1 FT Mid-IR  
 Total fat, g/dL (16)  224 3.4 ± 0.5 — Holder n/a Multiple FT Mid-IR  
 Total fat, g/dL (16)  14 2.9 ± 0.4 – Holder Colostrum n/a FT Mid-IR  
 Total fat, g/dL (17)  6 2.5 ± 0.3 2.2–3.0 Holder n/a n/a Mid-IR  
 Total fat, g/dL (19)  15 3.5 ± 1.3 1.4–6.0 Holder n/a n/a Creamatocrit  
 Total fat, g/dL (21)  179 3.1 ± 0.8 1.1–7.4 Raw n/a 1 Mid-IR  
 Total fat, g/dL (22)  33 3.5 ± 1.7 — Raw n/a n/a NMR  
 Total fat, g/dL (23)  16 3.9 ± 0.6 — Holder Preterm n/a FT Mid-IR  
 Total fat, g/dL (23)  21 3.7 ± 0.4 — Holder Term n/a FT Mid-IR  
 Total fat, g/dL (24)  30 2.8 ± 1.0 1.1–4.8 Holder Term n/a Creamatocrit  
 Total fat, g/dL (25)  3 3.4 ± 0.9 2.8–4.6 Holder 11% preterm 2 FT Mid-IR  
 Total fat, g/dL (25)  3 4.1 ± 0.2 3.9–4.6 Vat Holder n/a 250 FT Mid-IR  
 Total fat, g/dL (25)  3 3.0 ± 0.6 2.3–3.3 Retort n/a 200 FT Mid-IR  
 Total fat, g/dL (26)  1111 — 2.7–5.9 Holder n/a Target FT Mid-IR  
Minerals          
 Calcium, mg/L (14)  60 237 ± 53 — Holder n/a 1 Methylthymol blue  
 Calcium, mg/L (22)  33 220 ± 49 — Raw n/a n/a ICP-OES  
 Copper, mg/L (14)  60 0.5 ± 0.1 — Holder n/a 1 AA  
 Iron, μg/L (14)  60 660 ± 31 — Holder n/a 1 AA  
 Iron, μg/L (22)  33 230 ± 64 — Raw n/a n/a ICP-OES  
 Phosphorus, mg/L (14)  60 132 ± 32 — Holder n/a 1 AA  
 Potassium, mg/L (22)  33 390 ± 75 — Raw n/a n/a ICP-OES  
 Sodium, mg/L (22)  33 83 ± 31 — Raw n/a n/a ICP-OES  
 Zinc, mg/L (14)  60 1.7 ± 1.0 — Holder n/a 1 AA  
 Zinc, mg/L (22)  33 1.2 ± 0.7 — Raw n/a n/a ICP-OES  
Protein          
 Amino acids, μmol/L          
  Alanine (15)  16 224.6 ± 45.2 — Holder Term/preterm 3–4 Ion exchange HPLC  
  Arginine (15)  16 12.3 ± 4.2 — Holder Term/preterm 3–4 Ion exchange HPLC  
  Aspartate (15)  16 59.1 ± 16.8 — Holder Term/preterm 3–4 Ion exchange HPLC  
  Glutamate (15)  16 1415 ± 269 — Holder Term/preterm 3–4 Ion exchange HPLC  
  Glycine (15)  16 95.5 ± 23.2 — Holder Term/preterm 3–4 Ion exchange HPLC  
  Histidine (15)  16 22.7 ± 5.9 — Holder Term/preterm 3–4 Ion exchange HPLC  
  Isoleucine (15)  16 7.4 ± 2.4 — Holder Term/preterm 3–4 Ion exchange HPLC  
  Leucine (15)  16 28.7 ± 7.1 — Holder Term/preterm 3–4 Ion exchange HPLC  
  Lysine (15)  16 17.5 ± 7.0 — Holder Term/preterm 3–4 Ion exchange HPLC  
  Methionine (15)  16 4.4 ± 1.6 — Holder Term/preterm 3–4 Ion exchange HPLC  
Nutrient (citation) N Mean ± SD Range Treatment Donor type Donors/pool Analytical method 
  Phenylalanine (15)  16 13.5 ± 2.5 — Holder Term/preterm 3–4 Ion exchange HPLC  
  Proline (15)  16 26.2 ± 6.6 — Holder Term/preterm 3–4 Ion exchange HPLC  
  Serine (15)  16 95.4 ± 27.7 — Holder Term/preterm 3–4 Ion exchange HPLC  
  Taurine (15)  16 248.1 ± 54.7 — Holder Term/preterm 3–4 Ion exchange HPLC  
  Threonine (15)  16 71.2 ± 30.2 — Holder Term/preterm 3–4 Ion exchange HPLC  
  Tyrosine (15)  16 8.4 ± 3.1 — Holder Term/preterm 3–4 Ion exchange HPLC  
  Valine (15)  16 50.6 ± 9.9 — Holder Term/preterm 3–4 Ion exchange HPLC  
 Crude protein, g/dL (21)  179 0.8 ± 0.2 0.4–1.5 Raw n/a 1 Mid-IR  
 Total protein, g/dL (14)  60 1.2 ± 0.3 — Holder n/a 1 Lowry  
 Total protein, g/dL (15)  16 0.9 — Holder n/a 3–4 MilkOScope  
 Total protein, g/dL (16)  138 1.3 ± 0.4 — Holder n/a 1 FT Mid-IR  
 Total protein, g/dL (16)  224 1.5 ± 0.2 — Holder n/a Multiple FT Mid-IR  
 Total protein, g/dL (16)  14 2.0 ± 0.1 — Holder Colostrum n/a FT Mid-IR  
 Total protein, g/dL (17)  6 1.0 ± 0.1 0.8–1.1 Holder n/a n/a Mid-IR  
 Total protein, g/dL (19)  15 1.3 ± 0.2 1.0–1.6 Holder n/a n/a Bradford  
 Total protein, g/dL (22)  33 1.5 ± 0.2 — Raw n/a n/a Bicinchoninic acid  
 Total protein, g/dL (23)  16 1.4 ± 0.2 — Holder Preterm n/a FT Mid-IR  
 Total protein, g/dL (23)  21 1.1 ± 0.1 — Holder Term n/a FT Mid-IR  
 Total protein, g/dL (24)  30 3.2 ± 0.4 — Holder Term n/a Bradford  
 Total protein, g/dL (25)  3 1.0 ± 0.1 0.9–1.1 Holder 11% preterm 2 FT Mid-IR  
 Total protein, g/dL (25)  3 0.8 ± 0.0 0.8–0.8 Vat Holder n/a 250 FT Mid-IR  
 Total protein, g/dL (25)  3 0.8 ± 0.0 0.7–0.8 Retort n/a 200 FT Mid-IR  
 Total protein, g/dL (26)  1111 — 0.8–2.2 Holder n/a Target FT Mid-R  
 True protein, g/dL (21)  179 0.7 ± 0.2 0.3–1.2 Raw n/a 1 Mid-IR  
 Vitamins          
  Free choline, μmol/L (24)  30 170 ± 86 16–297 Holder Term n/a LC-MS/MS  
  GPC, μmol/L (24)  30 383 ± 195 61–772 Holder Term n/a LC-MS/MS  
  PhosC, μmol/L (24)  30 722 ± 255 51–1223 Holder Term n/a LC-MS/MS  
  WS choline, μmol/L (24)  30 1275 ± 414 128–1934 Holder Term n/a LC-MS/MS  
  Retinol, μg/L (14)  60 432 ± 266 — Holder n/a 1 HPLC  
  Retinol, μg/L (20)  1 185.8† — Holder n/a n/a HPLC  
  α-tocopherol, μg/L (20)  1 1381.9† — Holder n/a n/a HPLC  
  β-carotene, μg/L (20)  1 13.7† — Holder n/a n/a HPLC  
* Values interpreted from graphs. 
† N = 1 observation reported; data represent actual amounts, not measurements of central tendency and dispersion. 
AA, atomic absorption spectrometry; FT, Fourier transformed; GPC, glycerophosphocholine; HMO, human milk oligosaccharide; ICP-OES, inductive coupled 
plasma atomic emission spectroscopy; IR, infrared; LCPUFA, long chain PUFA; n/a, not available; MRM, multiple reaction monitoring; MS, mass spectroscopy; 
PhosC, phosphocholine; Target, selection of donors for pool based on macronutrient analysis of each donor; Transition, milk from 1–8 wk postpartum; UPLC, 




Six studies described the calorie composition of DHM (n = 3 to 224) with mean values between 
49.3 kcal/dL and 69.3 kcal/dL (16, 17, 19, 21, 23, 25). Five studies measured energy using infrared 
analysis. The largest study (n = 179) that provided information on ranges reported a minimum of 
46.0 kcal/dL and a maximum of 86.0 kcal/dL, which represents an almost 2-fold difference in 
energy (21). Four studies identified the energy conversion factors that were used to compute 
energy values from macronutrients (16, 17, 19, 25). While all 4 studies reported using the Atwater 
conversion factors of 4 kcal/g protein, 4 kcal/g carbohydrate, and 9 kcal/g fat, 2 of the studies 





Four studies assessed lactose in DHM (n = 6 to 60 samples), with mean values between 5.6 g/dL 
and 7.3 g/dL (14, 17, 19, 22). The largest study providing information on ranges (n = 15) reported a 
minimum lactose concentration of 5.7 g/dL and a maximum of 8.6 g/dL, which represents a 1.5-
fold difference in lactose (19). Studies that reported lactose values described using a variety of 
analytical methods including picric acid, enzymatic, chromatography coupled with tandem MS, 
and midinfrared. Four studies assessed total carbohydrates (n = 3 to 224), with mean values 
between 6.5 and 7.4 g/dL (16, 21, 23, 25). Only 1 study reported ranges for total carbohydrates 
(n = 3), and the difference between minimum and maximum total carbohydrate concentrations 
was <5% (25). Studies that reported total carbohydrate values all used infrared analysis as the 
analytical method. Three studies assessed total human milk oligosaccharides (HMOs) (n = 3 to 
33 samples) with mean values between 6.6 and 12.6 g/L (18, 22, 25). The largest study that included 
ranges for HMOs (n = 31) reported minimum values of 4 g/L and maximum values of 16 g/L, 




Total fat was assessed in 10 studies (n = 3 to 1111 samples), with mean values between 1.8 and 
4.1 g/dL (14, 16, 17, 19, 21–26). Two studies that contained over 100 samples reported ranges for fat of 
1.1 to 7.4 g/dL (n = 179) and 2.7 to 5.9 g/dL (n = 1111), which represents a 5.7-fold and 2.2-fold 
difference, respectively (21, 26). Total fat was assessed using a variety of analytical methods 
including midinfrared, Fourier-transformed midinfrared, NMR, and creamatocrit. Two studies 




Ten studies reported that they assessed protein (n = 3 to 1111 samples), with mean values 
between 0.8 g/dL and 3.2 g/dL (14–17, 19, 22–26). The largest study to include information on ranges 
(n = 1111) reported a minimum protein content of 0.8 g/dL and a maximum of 2.2 g/dL, which 
represents an almost 3-fold difference (26). Protein was assessed using a variety of methods 
including Bradford, bicinchoninic acid assay (BCA), Lowry, midinfrared, Fourier-transformed 
midinfrared, and ultrasound. One study (n = 179) used midinfrared analysis and reported crude 
protein values (min = 0.4 g/dL and max = 1.5 g/dL; 3.8-fold difference) and true protein values 
(min = 0.3 g/dL and max = 1.2 g/dL; 4-fold difference). A single study containing 16 samples 




Two studies (n = 33 and 60 samples) assessed minerals including calcium, copper, iron, 
phosphorus, potassium, sodium, and zinc. Methods of measuring minerals included atomic 
absorption, inductive coupled plasma optical emission spectrometry (ICP-OES), and 
methylthymol blue (calcium only) (14, 22). The only vitamins assessed were water-soluble choline 
compounds (n = 30), vitamin A (n = 1 and 60 samples), and vitamin E (n = 1 sample), and all 




In this review of the global literature on the nutrient composition of DHM we report that the 
protein, fat, and calorie composition of DHM can differ by 2-fold or more and that there is a 
dearth of information on the vitamin and mineral composition of DHM. Clinical implications of 
the demonstrated wide ranges of protein and energy strengthens the case for point-of-care 
analysis and targeted fortification of DHM. This research also suggests opportunities within 
donor milk banks to reduce the potential low nutritional content of DHM through nutrient 
analysis and targeted pooling (26). 
 
This review highlights the limited information available on the nutritional composition of DHM 
from commercial entities. We located only a single study reporting on donor milk obtained 
through 2 commercial entities that operate in the USA (3 samples from each company). In the 
USA, there are currently several commercial sources of donor milk (e.g., Prolacta, Medolac, Ni-
Q). Information regarding processing methods and donor recruitment is often not available for 
review and may lead to different nutritional profiles than findings from our review, which 
predominantly represent DHM produced in a milk bank setting. 
 
Macronutrient composition of DHM 
 
Carbohydrates, fat, and protein were the most frequently studied nutrients in DHM. For studies 
that reported minimum and maximum values, the magnitude of differences in the lactose and 
total carbohydrate concentrations in DHM was relatively small (<1.5-fold). The variability in 
protein was also <1.5-fold in all studies except 1, which reported an almost 3-fold difference. 
Conversely, 4 studies showed a 2-fold or greater difference in fat, with 3 of the studies showing 
4-fold or greater differences. This observation is consistent with the current literature on human 
milk composition which suggests that fat composition is highly variable between and within 
women and is influenced by a variety of factors including maternal diet and how the sample was 
collected (complete versus partial breast expression) (22, 27–31). Protein composition is strongly 
influenced by preterm birth and early lactation stage (32), which may explain some of the protein 
variability observed in this review; however, information on donor pregnancy term and lactation 
stage was not available for most of the included studies. It is difficult to draw meaningful 
conclusions on actual nutrient values from existing studies due to the use of a variety of 
analytical methods, many of which are not considered reference methods. While this limits the 
ability to draw comparisons between studies, an assessment of the results within studies provides 
insights into the potential range of nutrients found in DHM. Table 3 summarizes findings from 
this review and compares the published clinical references for human milk composition (33, 34). 
Importantly, the nutrition guidebook of the AAP reports reference calorie ranges for human milk 
of 65–70 kcal/dL (33). Nine of the 11 values we found in the literature for mean energy in DHM 
were below these AAP reference values. Similarly, 8 of 14 mean fat values reported were below 
clinical reference values of 3.5 g/dL, suggesting the need for updated clinical reference values 
that are specific to DHM. 
 
TABLE 3. Comparison of published clinical reference values for human milk composition 
compared with reviewed literature for donor human milk 
Nutrient AAP earlya AAP maturea AND pretermb AND DHMb Review of DHMc 
Protein, g/dL  1.6 0.9 2.1 1.2 0.8–2.2 
Fat, g/dL  2.0 3.5 4.5 3.2 1.1–7.4 
Carbohydrates, g/dL  0 — 7.5 7.8 7.0–7.3 
Lactose, g/dL  2.0–3.0 6.7 — — 5.5–8.6 
Energy, kcal/dL  — 65–70 77 65 43–86 
AAP, American Academy of Pediatrics; AND, Academy of Nutrition and Dietetics; DHM, donor human milk. 
a From the American Academy of Pediatrics' Pediatric Nutrition, 7th Edition (33). 
b From the Academy of Nutrition and Dietetics’ Infant and Pediatric Feedings, 3rd Edition (34). 
c Represents the collective ranges reported in reviewed studies. 
 
Micronutrient composition of DHM 
 
This review highlights the lack of available information on the vitamin and mineral composition 
of DHM, with only a few small studies reporting on limited numbers of micronutrients. This is 




A recent review on human milk composition conducted by the USDA's Nutrient Data Laboratory 
suggested the following standard reference methods for accurately measuring macronutrients in 
human milk: protein can be accurately measured using the sum of amino acids or Kjeldahl 
method, accounting for nonprotein nitrogen; total fat can be accurately measured via solvent 
extraction and gravimetric methods (e.g., Roese-Gottlieb, Folch) or by summing individual fatty 
acids measured by GC; lactose can be accurately measured by chromatography (8). These 
methods are also supported by Jensen and Neville in their handbook on human milk laboratory 
methods (35). The most common analytical method used for measuring macronutrients in the 
studies reviewed was infrared analysis. A growing body of evidence suggests that infrared 
analysis can reliably measure total nitrogen (e.g., crude protein) and fat in human milk, with 
appropriate sample handling and instrument calibration, though measurements of lactose were 
less accurate, and the measurement of total carbohydrates in human milk has not been validated 
(36–42). None of the reviewed studies used reference methods suggested by the USDA (8) to 
measure total protein or total fat, and only 1 study used reference methods for measuring lactose, 
which limits the ability to draw conclusions about actual nutrient ranges. For example, while the 
Lowry and BCA method have high correlations with reference methods for measuring protein 
(R2 ≥0.94) they may overreport actual protein values by 0.3 to 0.5 g/dL (43). Similarly, while 
creamatocrit was reported as highly correlated with fat measured by gravimetric reference 
methods (R2 = 0.99), it tended to underreport fat content by 0.3 to 0.6 g/dL (44). Finally, only 1 of 
the 14 studies provided information on how DHM was mixed prior to collecting the sample for 
analysis. Given that fat separates during storage, inadequate mixing could influence values 
obtained for the fat content of DHM. 
 
Impact of milk banking processes 
 
Included studies were inconsistent in reporting the milk banking processes that may impact 
nutritional composition, such as the number of donors per pool, and if targeted pooling was used 
to strategically combine donors based on the macronutrient analysis of the milk of the donor. A 
simulation of donor nutrient profiles from the Mother's Milk Bank of North Texas found that 
targeted pooling was more effective at reducing the fat variability in DHM than randomly 
pooling ≤5 donors per pool (26). Valentine et al. created pools of DHM using 3–4 donors per pool 
collected from 5 different HMBANA milk banks and found that the amino acid and fatty acid 
profiles did not significantly differ between pools, but was influenced by lactation stage (45). 
Future studies should collect milk bank pooling information and donor characteristics (e.g., 
lactation stage and pregnancy term) to identify potential process improvement opportunities 
within donor milk banking. 
 
Sources of bias and limitation 
 
In addition to different analytical methods and limited use of reference methods as a source of 
information bias, there was also missing information that contributed to information bias. For 
example, infrared analyzers typically measure crude protein based on total nitrogen and then 
estimate true protein by accounting for the nonnitrogen fraction in human milk. The nonprotein 
nitrogen fraction of human milk averages between 20–25% of the total nitrogen in human milk 
and can be ≤50% (37, 46, 47). Thus, if nonprotein nitrogen is not accounted for, protein values may 
be overestimated. Only 1 of the studies that measured protein with infrared analysis described 
whether they were reporting crude protein values or true protein values. Calorie information 
from this review is also subject to information bias as not all studies reported on the conversion 
factors used to compute energy from macronutrient values. Further, some studies used lactose to 
derive calorie values, while other studies used total carbohydrates. Previous studies have 
suggested that there is a 10–15% difference in the metabolizable compared with the gross energy 
in human milk, likely due to the HMOs and the nonprotein nitrogen fraction, which are 
theoretically unavailable sources of energy for the neonate (48, 49); therefore different methods of 
computing energy may bias results. This highlights the need to establish a standard approach to 
ensure uniformity in future studies and for translation to clinical nutrition delivery. There is 
selection bias present in these findings as most studies reflect DHM procured from a single milk 
bank in the HMBANA network. While these milk banks follow similar guidelines for DHM 
processing, regional differences in donors and milk-bank-specific practices may influence the 
nutritional composition of DHM. There was limited evidence of funding bias, with only 1 study 
partially funded by a milk bank and 2 studies funded by commercial entities. In these studies, 
there was no evidence that the funder played a role in study design or data interpretation. 
Additional limitations to this review include the small sample sizes within the included studies, 
and lack of any information on most vitamins and minerals. Finally, given that the reviewed 
studies were descriptive in nature and that the analytical methods were not consistent among 




These findings highlight the significant gap in the literature regarding the nutrient composition of 
DHM, with current evidence limited by both information and selection biases. Findings from the 
review suggest the potential for large variations in the fat, protein, and calorie composition of 
DHM based on small studies from a limited number of milk banks. Data on the vitamin and 




Further research is needed into the nutritional composition of DHM, with prioritization on 
measuring macronutrients and micronutrients using established reference methods as 
summarized by Wu et al. (8). Detailed descriptions of sample storage and handling practices must 
be included, as these factors may influence findings. To increase generalizability and allow for 
comparison among studies, future research should include more samples from multiple nonprofit 
and commercial milk banks. Further, collection of milk banking information (e.g., donors per 
pool, lactation stage, use of macronutrient analyzer), may provide insights into methods for 
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